Stocks
Health Care
crvs
Corvus Pharmaceuticals
NASDAQ: CRVS
+12.12 (+150.56%)
20.17
USD
At close at Jan 20, 21:40 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-27.54M
Pretax Income
-15.08M
Net Income
-62.29M
EBITDA
-62.21M
EBIT
-62.29M
Earnings Per Share
-0.9500000000000001
Balance Sheet
Cash & Cash Equivalents
8.93M
Total Debt
804.00K
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
32.39M
Book Value Per Share
0.54
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.